3rd Annual CHEP+ Conference
Clinical Practice Guidelines Update
Managing the Multi-Comorbid Patient
Bringing the Guidelines Together - Online (LIVE)
Saturday, March 27, 2021
8:45 a.m. - 3:15 p.m. (EDT)
This year’s conference is devoted to updates from Diabetes, Obesity, and Cardiac Rehabilitation and the latest clinical trial results and challenges facing the care of multi-morbidity patients with complex conditions with a focus on heart failure.
Early Bird Registration: $90
College of Family Physicians of Canada Mainpro+ (1 credit/hour) Group Learning: 6.0 credits and
(3 credit/hour) Group Learning: 9.0 credits*
Royal College Maintenance of Certification Section 1: 6.0 hours
*This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 9.00 Mainpro+ credits (including a practice reflection survey to be completed at 6 weeks after the session.
See below to view the Complete Program with Faculty and Agenda
Here at CHEP Plus, we are driven by a single goal; to do our part in improving health care quality and patient safety and health.
CHEP+ (C-CHANGE Education Program)
CHEP+ is a non-profit organization founded in 2018 representing the continuing education and professional development arm of the Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE).
Our mission is to improve health care quality and patient safety by supporting clinicians with enhanced professional development and health education.
CHEP+ brings together a multi-disciplinary group of healthcare professionals with the commitment to provide high quality, up-to-date continuing professional development programs with the aim of improving clinical practice and patient outcomes.
CHEP+ certified programs are designed to be engaging and relevant to health care professionals managing today’s complex patient.
"Family physicians witness the increasing complexity and multiple co-morbidities of patients in our clinics - CHEP Plus does a great job in bringing together CPD programs to help improve CVD health outcomes for our patients."